18.12.2012 Views

Floor plan - 2013 Annual Meeting - American Association for Hand ...

Floor plan - 2013 Annual Meeting - American Association for Hand ...

Floor plan - 2013 Annual Meeting - American Association for Hand ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Repairing Peripheral Nerve Injuries Using Skin-Derived Precursor Cells<br />

Institution where the work was prepared: University of Calgary, Hotchkiss Brain Institute, Calgary, AB, Canada<br />

Sarah K. Walsh, BSc; Raj Midha, MD, MSc; University of Calgary<br />

Previous work has shown that clones of progenitor cells isolated from the dermis of the neonatal and adult murine skin have the ability<br />

to differentiate in vitro into neural crest cell types, including peripheral neurons and glia. These cells, termed skin-derived precursors<br />

(SKPs), also respond to the milieu of the regenerating nerve in vivo and are able to differentiate into GFAP/S-100‚ positive Schwann cells<br />

when trans<strong>plan</strong>ted distal to a nerve injury. In our ongoing study, we are exploring the viability and differentiation of SKPs in various nerve<br />

injury models to ascertain their role in promoting nerve regeneration. To this end, the sciatic nerves of CD-1 mice were transected and<br />

chronically denervated. SKPs or SKP-SCs were injected into the subepineurium distal to the transection either immediately following<br />

injury or after 8 weeks of denervation. Immunohistochemical analysis 2-8 weeks following trans<strong>plan</strong>tation revealed survival and differentiation<br />

of both naïve and pre-differentiated SKPs, with 73% of the surviving cells injected after established chronic denervation<br />

expressing Schwann cell markers. Eight weeks following SKP trans<strong>plan</strong>t, survival of pre-differentiated SKPs was significantly higher than<br />

that of the naïve preparation. This study also examined the potential <strong>for</strong> SKPs to improve nerve regeneration across a gap bridged by<br />

a freeze-thawed nerve graft. Donor sciatic nerves were collected from adult Lewis rats and decellularized by repeated cycles of freezing<br />

in liquid nitrogen and thawing in warm water bath. These syngeneic grafts were then used to bridge a 12 mm nerve injury gap in<br />

Lewis rat recipients and SKPs-SCs or cultured Schwann cells were injected into the grafted area. Immunohistology after 4 weeks showed<br />

survival of both cell types and early regeneration in SKP seeded grafts (as deemed by NF-stained axon counts) was comparable to those<br />

seeded with Schwann cells. We expect that morphometrical and electrophysiological measurements of cell-treated nerve segments<br />

after 8 weeks survival will show a similar contribution to regeneration. We there<strong>for</strong>e conclude that SKPs represent an accessible, autologous<br />

source of Schwann cells <strong>for</strong> trans<strong>plan</strong>tation therapies that have the potential to survive over long time periods and improve<br />

regeneration outcomes.<br />

DASH as a Measurement of Outcome in Adult Brachial Plexus Reconstruction<br />

Institution where the work was prepared: Mayo Clinic, Rochester, MN, USA<br />

Keith A. Bengtson; Alexander Shin; Robert Spinner; Allen Bishop; Michelle Kircher; Mayo Clinic<br />

No clear consensus exists on how to measure outcomes after adult brachial plexus reconstruction. The BMRC muscle strength scale is<br />

the most popular measuring tool used to date. Un<strong>for</strong>tunately, this method has many shortcomings including its imprecision, lack of<br />

inter-rater reliability, as well as the wide range of strength that is covered by the grade of 4/5. The DASH, however, “is the most validated<br />

measure of upper extremity function in upper extremity disorders. The instrument's ease of use in a heterogeneous sample is possibly<br />

its greatest advantage.” (Dowrick 2005). No studies have been published that measure DASH scores both be<strong>for</strong>e and after brachial<br />

plexus reconstruction. The purpose of this study is to illustrate the usefulness of the DASH as an outcome measure in adult brachial<br />

plexus reconstruction. Between the dates of November 2004 and October 2006, 34 patients underwent reconstruction of brachial<br />

plexus injuries and completed both pre-operative and post-operative DASH questionnaires. Time of follow-up questionnaire ranged<br />

from 5 months to 26 months (average of 15.4 months) depending on type of surgery and expected time period <strong>for</strong> neurologic recovery.<br />

Improvement in DASH scores ranged from -27.5 (greater disability) to +29.2 with an average improvement of 11.2. Five different<br />

patient groups were included based on type of neurologic injury. Each group showed a significant change in DASH score be<strong>for</strong>e and<br />

after surgical intervention. Such responsiveness to change would indicate that the DASH is a sensitive outcome tool <strong>for</strong> the study of<br />

adult brachial plexus reconstruction.<br />

REFERENCE:<br />

Dowrick AS. Gabbe BJ. Williamson OD. Cameron PA. Outcome instruments <strong>for</strong> the assessment of the upper extremity following trauma:<br />

a review. Injury. 36(4):468-76, 2005 Apr.<br />

127

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!